HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the ...

Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as "Ping An Bio") announced that it has entered into a non-binding memorandum (the "Investment ...

Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly accurate diagnostic delivers results to patients in just 15 minutes—up to ...

Ping An Biomedical Co., Ltd. is a one-stop SCM service provider in the apparel industry. It is also a forward-thinking company dedicated to delivering innovative solutions in healthcare and biomedical ...

Sleep apnea is a disorder characterized by repeated obstructions or collapses of the upper airway during sleep. These ...

Pennington Biomedical Research Center’s Associate Executive Director for Cores and Resources, Dr. Jennifer Rood, has agreed ...

Future FinTech a leading comprehensive financial and digital technology service provider, announced today that on January 7, 2026, its wholly-owned subsidiary, Future FinTech (Hong Kong) Limited ...

Logan Jenner, a five-year-old battling acute myeloid leukemia, found new hope through a clinical trial that used Functional Precision Medicine to guide a personalized treatment approach after standard ...

Ping An Biomedical Co., Ltd (NASDAQ:PASW) stock tumbled 31% on Friday after the company announced a strategic investment plan in Future Biotechnology Group. The b ...

Nanoparticle technology offers significant market opportunities in pharmaceuticals and biomedicine, enhancing drug delivery, solubility, and targeted therapy. This field supports advancements in ...

Explore the booming Global Nanobubbles Market 2026-2036 with substantial growth opportunities in agriculture, aquaculture, biomedical, and environmental remediation. This market intelligence report ...

As of Wednesday, December 24, Impact BioMedical Inc.’s IBO share price has dipped by 5.93%, which has investors questioning if this is right time to buy.